QT prolongation

There are 2 papers on QT prolongation in aging research: 1 observational study in people, 1 review. The newest story, Nov 7, 2026: “No clear antipsychotic–death link in schizophrenia with dementia”.

Disease

2 papers study it20 more mention it

4 new papers in 30 daysSee all 22 papers on QT prolongation

  • Humans1

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 2Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 2Nov 2026: 211 papers in 12 months
Progress in Neuro-psychopharmacology & Biological Psychiatry

No clear antipsychotic–death link in schizophrenia with dementia

The adjusted hazard ratio—a relative measure of death risk—was 0.976 for early prescriptions versus none recorded, with no statistically significant difference.The adjusted hazard ratio—a relative measure of death risk—was 0.976 for early prescriptions versus none recorded, with no statistically significant difference.

Cohort · 28,506 peopleSchizophrenia
bioRxiv

Protein loss worsened age-related heart changes in mice

Mice lacking a signaling protein developed greater heart thickening, scarring and susceptibility to abnormal rhythms than age-matched controls in an animal experiment.Mice lacking a signaling protein developed greater heart thickening, scarring and susceptibility to abnormal rhythms than age-matched controls in an animal experiment.

Preprint: mouse studyMechanisms

See all 22 papers on QT prolongation